Provider
QP38-24 Training Webinars for New Prior Authorization Submission Process
Program effective Date: May 22, 2024
Documents & Forms Results
Displaying 501 - 510 of 3642 results
Provider
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Program effective Date: May 08, 2024
Provider
QP43-24 MHCP Pharmacy Benefit Exclusion for Alyglo™ and Lenmeldy™
Program effective Date: May 08, 2024
Provider
QP42-24 Commercial Pharmacy Benefit Exclusion for Lenmeldy™
Program effective Date: May 08, 2024
Provider
QP41-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: May 08, 2024
Provider
QP39-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2024
Program effective Date: May 08, 2024
Provider
QP40-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
Program effective Date: May 08, 2024
Provider
2024 May Bulletins
Program effective Date: May 01, 2024
Provider
P34-24 Updated Reimbursement Policies, Effective July 1, 2024
Program effective Date: May 01, 2024